Small (≤3 cm) hepatocellular carcinoma in cirrhosis: The role of double contrast agents in MR imaging vs. multidetector-row CT;Ruolo della RM a doppio contrasto rispetto alla TC multidetettore nella diagnosi del piccolo epatocarcinoma (≤3 cm) su cirrosi

Radiologia Medica

Volumn 114, Issue 8, 2009, Pages 1239-1266

  Golfieri, R ^a   Marini, E ^a   Bazzocchi, A ^a   Fusco, F ^a   Trevisani, F ^a   Sama, C ^a   Mazzella, G ^a   Cavuto, S ^b   Piscaglia, F ^a   Bolondi, L ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cirrhosis; Contrast agents; Gd DTPA enhanced MRI; Hepatocellular carcinoma; Liver; Multiphasic helical multidetector row CT (MDCT); Neoplasms; SPIO enhanced MRI

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE; MAGNETITE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; FERROSOFERRIC OXIDE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 75949118403     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-009-0439-x     Document Type: Article

References (48)

1. Bruix J, Sherman M, Llovet JM et al (2001) EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421-430
2. Bruix J, Sherman M (2005) Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42:1208-1236
3. Willatt JM, Hussain HK, Adsumilly S et al (2008) MR imaging carcinoma in the cirrhotic liver: challenges and controversies. Radiology 247:311-328
4. Colli A, Fraquelli M, Casazza G et al (2006) Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 101:513-523
5. Forner A, Vilana R, Ayuso C et al (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47:97-104
6. Hecht EM, Holland AE, Israel GM et al (2006) Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology 239:438-447
7. Rode A, Bancel B, Douek P et al (2001) Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 25:327-336
8. Burrel M, Llovet JM, Ayuso C et al (2003) Barcelona Clinic Liver Cancer Group. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 38:1034-1042
9. Lencioni R, Della Pina C, Bruix J et al (2005) Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography. Dig Dis Sci 50:533-537
10. Bluemke DA, Paulson EK, Choti MA et al (2000) Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT. AJR Am J Roentgenol 175:1653-1658
11. Kang BK, Lim JH, Kim SH et al (2003) Preoperative depiction of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT. Radiology 226:79-85
12. Kim SH, Choi D, Kim SH et al (2005) Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 184:1069-1076
13. Kim YK, Kwak HS, Kim CS et al (2006) Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO enhanced MR imaging and 16-detector row CT. Radiology 238:531-541
14. Vogl TJ, Schwarz W, Blume S et al (2003) Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)- enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol 13:262-272
15. Choi D, Kim SH, Lim JH et al (2001) Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus combined CT during arterial portography and CT hepatic arteriography. AJR Am J Roentgenol 176:475-482 (Pubitemid 32105665)
16. Kim MJ, Kim JH, Chung JJ et al (2003) Focal hepatic lesions: detection and characterization with combination gadolinium-and superparamagnetic iron oxide-enhanced MR imaging. Radiology 228:719-726
17. Ward J, Guthrie JA, Scott DJ et al (2000) Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 216:154-162
18. Bhartia B, Ward J, Guthrie JA et al (2003) Hepatocellular carcinoma in cirrhotic livers: double-contrast thinsection MR imaging with pathologic correlation of explanted tissue. AJR Am J Roentgenol 180:577-584
19. Hanna RF, Kased N, Kwan SW et al (2008) Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis. AJR Am J Roentgenol 190:47-57
20. Hanna RF, Aguirre DA, Kased N et al (2008) Cirrhosis associated Hepatocellular Nodules: Correlation of Histopathologic and MR Imaging Features. Radiographics 28:747-769
21. de Ledinghen V, Laharie D, Lecesne R et al (2002) Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients. Eur J Gastroenterol Hepatol 14:159-165
22. Nakamura H, Ito N, Kotake F et al (2000) Tumor-detecting capacity and clinical usefulness of SPIO-MRI in patients with hepatocellular carcinoma. J Gastroenterol 35:849-855
23. Kwak HS, Lee JM, Kim YK et al (2005) Detection of hepatocellular carcinoma: comparison of ferumoxidesenhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging. Eur Radiol 15:140-147
24. Pauleit D, Textor J, Bachmann R et al (2002) Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Radiology 222:73-80
25. Tang Y, Yamashita Y, Arakawa A et al (1999). Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. AJR Am J Roentgenol 172:1547-1554
26. Tanimoto A, Kuribayashi S (2006) Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol 58:200-216
27. Simon G, Link TM, Wortler K et al (2005) Detection of hepatocellular carcinoma: comparison of Gd-DTPAand ferumoxides-enhanced MR imaging. Eur Radiol 15:895-903
28. Jeong YY, Mitchell DG, Kamashima T (2002) Small (< 20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 178:1327-1334
29. Shimizu A, Ito K, Koike S et al (2003).Cirrhosis or chronic hepatitis: evaluation of small (≤ 2 cm) earlyenhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology 226:550-555
30. Holland AE, Hecht EM, Hahn WY et al (2005) Importance of small (≤ or =20- mm) enhancing lesions with whole explanted liver seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole esplanted liver. Radiology 237:938-944
31. Oudkerk M, van den Heuvel AG, Wielopolski PA et al (1997) Hepatic lesions: detection with ferumoxideenhanced T1-weighted MR imaging. Radiology 203:449-456
32. Bolondi L, Gaiani S, Celli N et al (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27-34
33. Bartolozzi C, Crocetti L, Lencioni R et al (2007) Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 17:2519-2530
34. Kojiro M (2004) Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl 10:S3-S8
35. Imai Y, Murakami T, Yoshida S et al (2000) Superparamagnetic iron oxideenhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 32:205-212
36. Lim JH, Choi D, Cho SK et al (2001) Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 220:669-676
37. Qayyum, A, Thoeni RF, Coakley FV et al (2006) Detection of hepatocellular carcinoma by ferumoxides-enhanced MR imaging in cirrhosis: incremental value of dynamic gadoliniumenhancement. J Magn Reson Imaging 23:17-22
38. Mori K, Scheidler J, Helmberger T et al (2002) Detection of malignant hepatic lesions before orthotopic liver transplantation: accuracy of ferumoxides-enhanced MR imaging. AJR Am J Roentgenol 179:1045-1051
39. Krinsky GA, Lee VS, Thiese ND et al (2001) Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 219:445-454
40. Krinsky GA, Lee VS, Theise ND et al (2002) Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging. Liver Transpl 8:1156-1164
41. Tanaka M, Nakashima O, Wada Y et al (1996) Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic lesions in the liver. Hepatology 24:807-812
42. Ransohoff DF, Feinstein AR (1978) Problems of spectum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 299:926-930
43. Bossuyt PM, Reitsma JB, Bruns DE et al (2003) Standards for reporting of diagnostic accuracy the STARD statement for reporting studies of diagnostic accuracy explanation and elaboration. Ann Intern Med 138:W1-W12
44. Tanimoto A, Yuasa Y, Shinmoto H et al (2002) Superparamagnetic iron oxide mediated hepatic signal change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function. Radiology 222:661-666
45. Macarini L, Marini S, Milillo P et al (2006) Double-contrast MRI (DC-MRI) in the study of the cirrhotic liver: utility of administering Gd-DTPA as a complement to examinations in which SPIO liver uptake and distribution alterations (SPIO-LUDA) are present and in the identification and characterisation of focal lesions. Radiol Med 111:1087-1102
46. Ishiyama K, Hashimoto M, Izumi J et al (2008) Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors. J Magn Reson Imaging 27:1322-1326
47. Lutz AM, Goepfert K, Willmann JK et al (2005) Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium and superparamagnetic- iron oxide-enhanced T1-weighted MR images. Radiology 237:520-528
48. Marrero JA, Hussain HK, Nghiem HV et al (2005) Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 11:281-289